Resources


Go Back

Cardiovascular case study: Global Phase III Study – Heart Failure & Actigraphy

18 May 2017

After case studies about autoimmune & skin diseases, psoriasis and oncology, Kayentis releases its cardiovascular case study regarding heart failure and actigraphy. Kayentis offers combined eCOA / ePRO expertise in cardiovascular and medical device.

Global Phase III study – Cardiovascular & heart failure

  • 600 patients
  • 150 sites
  • 20 countries
  • 26 languages

Challenges of the cardiovascular case study

  • An eCOA partner that could deliver an ePRO solution combined with proven data management and actigraphy expertise.
  • On-site ePRO solution and data management of actigraphy data.
  • Short study set-up timelines and interaction with the sponsor and different CROs for study implementation.

Frédérique MARION, Kayentis Business Development Director – May, 18, 2017

To download this case study, please click here:

Kayentis ePRO cardiovascular case study

Last update: 2018, January

Agenda

  • 06 June
    PCMG Annual Conference - June 6 - 8th June – Valletta, Malta - Schedule a meeting with Kayentis
  • 12 June
    OCT London - June 12th & 13th, London, UK - Schedule a meeting with Kayentis OCT London 2018
  • 24 June
    DIA 2018 Annual Meeting - June 24th-28th - Boston, MA - Booth #724 Schedule a meeting with Kayentis DIA Boston June 2018
  • 30 October
    OCT Nordics - October 30th & 31st - Copenhagen, Denmark - Booth #10 - Schedule a meeting with Kayentis OCT Nordics 2018
  • Follow us

    Download our brochure